New hope for tough cancers: first patients test novel drug
Disease control
Recruiting now
This is the first study in people to test a new immunotherapy drug called PMC-309. It aims to see if the drug is safe and how the body processes it when given alone or with another cancer drug, pembrolizumab. The study is for adults with advanced solid tumors that have spread or …
Phase: PHASE1 • Sponsor: PharmAbcine • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC